Ren Zhang, PhD
Scott Hall, Rm 3319
540 E. Canfield St
Detroit, MI 48201
313-577-0027
rzhang@med.wayne.edu
Education
UT MD Anderson Cancer Center, PhD, 2005
Research Focus
Metabolism in health and disease. Metabolic syndrome is becoming a public health burden. The Ren Zhang lab identified two novel metabolism regulators: 1) lipasin and 2) MNADK (later known as ANGPTL8 and NADK2, respectively), both being encoded by previously uncharacterized genes. The lab studies the functions and mechanisms of ANGPTL8 and NADK2 in mediating lipid and glucose metabolism.
1) ANGPTL8 regulates triglyceride partitioning between fat and oxidative tissues. The human body stores energy during feasting while using the energy that has been stored during famine, a mechanism that helped human ancestors survive during evolution. As a fundamental physiological process, triglyceride (TG, the main energy source) is stored in white adipose tissue (WAT) after food intake while during fasting it is routed to oxidative tissues (heart and skeletal muscle) for energy production, a process referred to as TG partitioning.
The Zhang lab initially identified a novel TG metabolism regulator, lipasin (later known as ANGPTL8), and then proposed the ANGPTL3-4-8 model, which explains the mechanism for TG partitioning during the fed-fast cycle (Fig. 1). Research on ANGPTL3, 4, and 8 can hopefully provide more insights into human health, disease, and therapeutics. |
||
2) MNADK phosphorylates NAD(H) to generate mitochondrial NADP(H). Nicotinamide adenine dinucleotide (NAD), a coenzyme, is essential for metabolism. NAD phosphate (NADP) and its reduced form NADPH play crucial roles for fatty acid β-oxidation and for neutralizing reactive oxygen species (ROS). Mitochondria are an important source of ROS, but because NADP cannot pass through the mitochondrial membrane, the source of human mitochondrial NADP remained elusive for years. The Zhang lab discovered that the uncharacterized human gene C5ORF33 encodes the long-sought mitochondrion-localized NAD kinase, named MNADK (later known as NADK2). MNADK phosphorylates NAD(H) to generate mitochondrial NADP(H). Later studies showed that MNADK-deficient patients exhibit symptoms characteristic of mitochondrial disease, and that Mnadk knockout mice phenocopy the MNADK-deficient patients. MNADK is critical for generating mitochondrial NADP(H) and for maintaining its redox balance in mammalian cells (Fig. 2). |
Fig. 2. In mammalian cells, NADK2 phosphorylates NAD(H) to generate mitochondrial NADP(H). NAD(H) represents NAD+ and NADH. NADP(H) represents NADP+ and NADPH. NADK phosphorylates NAD+ to generate cytosolic NADP+. |
Mentoring
Accepting new M.S. students in 2024-2025
Accepting new Ph.D. students in 2024-2025
Recent Publications
-
Fu, Z, Chen, Q, Zhang, K and Zhang, R, A comparison between canonical and alternative pathways in triglyceride synthesis, J. Endocrinology and Metabolism, 2024, in press.
-
Zhang, R and Zhang K, A unified model for regulating lipoprotein lipase activity, Trends in Endocrinology and Metabolism, 2024, 35:490-504.
-
Zhang, R and Zhang K, Mitochondrial NAD kinase in health and disease, Redox Biology, 2023, 60:102613.
Featured in Medicine Innovates.
-
Kim H, Song Z, Zhang R, Davies BSJ, Zhang K. A hepatokine derived from the ER protein CREBH promotes triglyceride metabolism by stimulating lipoprotein lipase activity. Science Signal. 2023, 16:eadd6702.
-
Zhang C, Salamon J, and Zhang R, Correlations between the changing levels of tissue plasminogen activator and adiposity following exercise-induced weight loss. Nutrients, 2022, 14, 5159.
-
Fu Z, Kim H, Morse PT, Lu M, Hüttemann M, Cambronne X, Zhang K and Zhang R, The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions. Metabolism, 2022, 135: 155275.
-
Kim H, Fu Z, et. al, Zhang R, Zhang K, The mitochondrial NAD kinase functions as a major metabolic regulator upon increased energy demand. Mol. Metabolism, 2022, 64: 101562.
-
Ren Zhang (Editor), 2022, Essential Genes and Genomes. Springer/Humana Press (10.1007/978-1-0716-1720-5)
Comprehensive and authoritative, Essential Genes and Genomes: Methods and Protocols is an ideal guide for researchers attempting to strip genetics down to its fundamentals. |
-
Zhang R, Zhang K, An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues. 2021, Progress in Lipid Research, 85, 101140.
-
Zhang R, The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels. 2021, Front. Cardiovasc. Med., 8, 795370.
-
Hao L, Yan L, Tao L, Lai F, Zhang C, Gao F, and ZHANG R. DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools. Nucleic Acids Research, 2021, 49:D677-D686.
“Highly Cited Paper”, selected by Web of Science (Thomson Reuters) as the citation being at top 1% of the academic field of Biology & Biochemistry.
-
Kim H, Williams D, Qiu Y, Song Z, Yang Z, Kimler V, Goldberg A, ZHANG R, Yang Z, Chen X, Wang L, Fang D, Lin JD, Zhang K. Regulation of hepatic autophagy by stress-sensing transcription factor CREBH. FASEB J. 2019, 33:7896-7914.
-
Zhang K, Kim H, Fu Z, Qiu Y, Yang Z, Wang J, Zhang D, Tong X, Yin L, Li J, Wu J, Qi NR, Houten SM, ZHANG R. Deficiency of the mitochondrial NAD kinase causes stress-induced non-alcoholic steatohepatitis. Gastroenterology, 2018, 154: 224–237.
-
Chi X, Britt EC, Shows HW, Hjelmaas AJ, Shetty SK, Cushing EM, Li W, Dou A, ZHANG R, Davies BSJ. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase. Mol Metab. 2017; 6:1137-1149.
-
ZHANG R. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking. Open Biology, 2016;6:150272.
Among the 10 most cited articles published by Open Biology in the past decade.
-
Fu Z, Abou-Samra AB, ZHANG R. A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase. Sci Rep. 2015; 5:18502.
-
ZHANG R. MNADK, a Long-Awaited Human Mitochondrion-Localized NAD Kinase. J Cell Physiol. 2015;230:1697-701.
-
Zhang C, ZHANG R. More effective glycaemic control by metformin in African Americans than in Whites in the prediabetic population. Diabetes Metab. 2015;41:173-5.
-
Zhang C, Luo H, Gao F, Zhang CT, ZHANG R. A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program. Acta Diabetol. 2015;52:625-8.
-
Zhang C, Gao F, Luo H, Zhang CT, ZHANG R. Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity. Cardiovasc Diabetol. 2015;14:79.
-
Gao F, Luo H, Fu Z, Zhang CT, ZHANG R. Exome sequencing identifies novel ApoB loss-of-function mutations causing hypobetalipoproteinemia in type 1 diabetes. Acta Diabetol. 2015;52:531-7.
-
Gao F, Luo H, Zhang CT, ZHANG R. Gene essentiality analysis based on DEG 10, an updated database of essential genes. Methods Mol Biol. 2015;1279:219-33.
-
ZHANG R, Abou-Samra AB. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol. 2014;13:133.
-
Luo H, Lin Y, Gao F, Zhang CT, ZHANG R. DEG 10, an update of the database of essential genes that includes both protein-coding genes and noncoding genomic elements. Nucleic Acids Res. 2014;42:D574-80.
“Highly Cited Paper”, selected by Web of Science (Thomson Reuters) as the citation being at top 1% of the academic field of Biology & Biochemistry.
-
Kim H, Mendez R, Zheng Z, Chang L, Cai J, ZHANG R, Zhang K. Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor alpha to regulate metabolic hormone FGF21. Endocrinology. 2014;155:769-82.
-
Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, ZHANG R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep. 2014;4:5013.
“Highly Cited Paper”, selected by Web of Science (Thomson Reuters) as the citation being at top 1% of the academic field of Biology & Biochemistry.
-
Fu Z, Abou-Samra AB, ZHANG R. An explanation for recent discrepancies in levels of human circulating betatrophin. Diabetologia. 2014;57:2232-4.
-
ZHANG R, Abou-Samra AB. Emerging roles of Lipasin as a critical lipid regulator. Biochem Biophys Res Commun. 2013;432:401-5.
-
ZHANG R. MNADK, a novel liver-enriched mitochondrion-localized NAD kinase. Biol Open. 2013;2:432-8.
-
Fu Z, Yao F, Abou-Samra AB, ZHANG R. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun. 2013;430:1126-31.
-
ZHANG R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424:786-92.
-
ZHANG R, Lin Y. DEG 5.0, a database of essential genes in both prokaryotes and eukaryotes. Nucleic Acids Res. 2009, 37:D455-8.
-
ZHANG R, Maratos-Flier E, Flier JS. Reduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B. Endocrinology. 2009;150:3076-82.
-
ZHANG R, Dhillon H, Yin H, Yoshimura A, Lowell BB, Maratos-Flier E, Flier JS. Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight. Endocrinology. 2008;149:5654-61.
-
ZHANG R, Murakami S, Coustry F, Wang Y, de Crombrugghe B. Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation. PNAS. 2006;103:365-70.
The complete list of publications at NCBI My Bibliography and Google Scholar.